Safety and Early Signs of Efficacy of IL12-L19L19. | MicrobiomeTrials← Back to trialsNCT04471987
Safety and Early Signs of Efficacy of IL12-L19L19.
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2020-07-01Est. Completion: 2026-12
Enrollment target: 80 participants Locations- Universitaetsklinik Hamburg-Eppendorf, Hamburg, Free and Hanseatic City of Hamburg, Germany
- Universitätsklinikum Heidelberg, Nationalen Centrum für Tumorerkrankungen (NCT), Dermatoonkologie, Heidelberg, Heidelberg, Germany
- Universitätsklinikum Leipzig, Klinik für Dermatologie, Venerologie und Allergologie, Leipzig, Leipzig, Germany
- Universitätsklinikum Tübingen, Klinik für Innere Medizin VIII Medizinische Onkologie und Pneumologie, Tübingen, Germany
- IEO - Istituto Europeo di Oncologia, Milan, Italy, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Italy
- Universitätsspital Basel, Basel, Basel, Switzerland
- Insel Gruppe AG, Bern, Canton of Bern, Switzerland
- Geneva University Hospital, Oncology Department, Geneva, Canton of Geneva, Switzerland
- Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Other microbiome trials you might be interested in
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oropharyngeal Squamous Cell CarcinomaStage II Laryngeal Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8Stage III Lip and Oral Cavity Cancer AJCC v8
Contact
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Lip and Oral Cavity Cancer AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
This phase II trial tests the addition of chemotherapy, with carboplatin and paclitaxel, or chemo-immunotherapy, with ca…
Tucson, United StatesEst. completion Feb 1, 2033
Metastatic Breast Cancer
This is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with met…
Duarte, United StatesEst. completion Sep 30, 2030